跳至主要内容
临床试验/NCT02678650
NCT02678650Unknown4 期

Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University

Liang Zhang1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
60
试验地点
1
主要终点
microRNA

研究概览

简要总结

It has been reported that volatile anesthetics preconditioning mediates protection of organ via microRNA. We want to study on the effects of isoflurane preconditioning on expression of microRNA and mRNA in the specimens of internal mammary artery and ascending aorta.

详细描述

  1. Sixty patients scheduled for off-pump coronary artery bypass surgery were randomly assigned to isoflurane wash-in/wash-out group(S-I group, n=30)or propofol intravenous anesthesia group(P group, n=30).
  2. Anesthesia and monitoring method All patients were monitored according to the American Society of Anesthesia guidelines and received standard general induction of anesthesia.
  3. SI group:10min after intubation,begin to isoflurane wash-in/wash-out operation:isoflurane administration was interrupted for at least 10 min,by washout with a high fresh gas flow(10 l/min)to achieve a MAC value below 0.2. Following the interruption,sevoflurane was again washed in with a high fresh gas flow(6 l/min)to achieve 1 MAC end-tidal concentration as soon as possible,and repeated twice periods of 10 minutes.Discontinuation of the halogenated agent for at least 15 minutes during the last wash out time.
  4. P Group:propofol infusion 3-5μg/kg/h.
  5. When isoflurane inhaled anesthetic,propofol are stopped infusion.If during this interruption the BIS value increased to>50,0.5 mg/kg propofol was administered repeatedly in boluses until the BIS value have returned to<50.

6.1h after isoflurane preconditioning,specimens of internal mammary artery(surplus arterial tissue is obtained from the repair internal mammary artery)and ascending aorta(the stump after ascending aortic punch)will be saved, and before isoflurane preconditioning,1h,3h,5h after isoflurane preconditioning, central venous blood samples will also be drawn.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age >18 years
  • written informed consent;
  • scheduled procedures;
  • planned isolated OPCABG(multiple bypass are allowed; planned combined intervention such as CABG plus valve surgery are not allowed);
  • ejection fraction> 50%;
  • NYHA class Ⅱ~Ⅲ;
  • serum creatinine <150μmol / l;
  • preoperative platelet content > 100 × 109 / l;
  • preoperative hemoglobin> 120 g / l

排除标准

  • pregnancy;
  • planned valve surgery or surgery on the aorta;
  • left main coronary artery stenosis> 75%;
  • echocardiographic examination revealed moderate to severe mitral, tricuspid, or aortic regurgitation or stenosis;
  • unstable or ongoing angina;
  • recent (< 1 month) or ongoing acute myocardial infarction;
  • use of sulfonylurea, theophylline or allopurinol;
  • previous unusual response to an anesthetic agent;
  • inclusion in other randomised controlled studies in the previous 30 days; (10)any general anesthesia performed in the previous 30 days;
  • emergency operation (not scheduled);
  • kidney or liver transplant in medical history, liver cirrhosis (Child B or C);
  • chronic respiratory disease (such as chronic obstructive pulmonary emphysema)

研究组 & 干预措施

volatile anesthetics group

Experimental

10min after intubation, begin to sevoflurane wash-in / wash-out operation: sevoflurane administration was interrupted for at least 10 min, by washout with a high fresh gas flow (10 l/min) to achieve a MAC value below 0.2. Following the interruption, sevoflurane was again washed in with a high fresh gas flow (6 l/min) to achieve 1 MAC end-tidal concentration as soon as possible, and repeated twice periods of 10 minutes. Discontinuation of the halogenated agent for at 15 minutes during the last wash out time.

干预措施: volatile anesthetics(isoflurane) (Drug)

propofol intravenous anesthesia group

Placebo Comparator

propofol infusion 3-5μg / kg / h

干预措施: propofol intravenous anesthesia (Drug)

结局指标

主要结局

microRNA

时间窗: 1h after isoflurane treatment(specimens of internal mammary artery and ascending aorta stump are saved)

NOS3 mRNA,mRNA levels of adhesion molecule selectin -E,vascular cell adhesion molecule -1,vascular endothelial growth factor -1,intercellular adhesion molecule,RhoA and ROK

时间窗: 1h after isoflurane treatment(specimens of internal mammary artery and ascending aorta stump are saved)

phosphatidylinositol-3-kinase,alanine aminotransferase,endothelial nitric oxide synthase

时间窗: 1h after isoflurane treatment(specimens of internal mammary artery and ascending aorta stump are saved)

次要结局

  • Change from microRNA(befor isoflurane treatment,1h,3h,5h after isoflurane treatment(central venous blood samples are drawn))
  • Change from ON content in serum,vascular cell adhesion molecule-1,intercellular adhesion molecules-1,adhesion molecule selectin-E,monocyte chemoattractant protein-1 and vascular endothelial growth factor-1(befor isoflurane treatment,1h,3h,5h after isoflurane treatment(central venous blood samples are drawn))
  • Change from tumor necrosis factor-a,interleukin 1β,IL-6,IL-8 and IL-10(befor isoflurane treatment,1h,3h,5h after isoflurane treatment(central venous blood samples are drawn))

研究者

发起方
Liang Zhang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Liang Zhang

Principal Investigator

Beijing Anzhen Hospital

研究点 (1)

Loading locations...

相似试验